Clinical Trials Browser

INDUSTRY × masitinib × Sarcoma × Clear all

NCT00812240 2023-02-01

Masitinib in First Line Treatment of Gastro-Intestinal Stromal Tumor (GIST)

Phase 3 Terminated

GastrointestinalSarcoma

Neoplasm Metastasis, Gastrointestinal Stromal Tumors

NCT01694277 2020-12-08

Masitinib in Patients With Gastrointestinal Stromal Tumour After Progression With Imatinib

Phase 3 Completed

GastrointestinalSarcoma

Neoplasm Metastasis, Gastrointestinal Stromal Tumors